**Meet the editor**

Dr. Patricio A. Pacheco is a Chilean/British ophthalmologist who early in his career moved from his native country Chile to work in the UK. He is a member of the British Medical Association and former affiliate member of the Royal College of Ophthalmologists. After graduating as Medical Doctor (MD) from the University of Chile in 2001, he underwent specialist training in

ophthalmology at the renowned Ophthalmology Department and Ocular Trauma Unit, Hospital del Salvador, funded by Prof. Raymundo Charlin early last century, in Santiago, Chile. On completing his specialist training and after graduating with first class honours, he travelled to the UK in 2004 for subspecialist training in cornea and anterior segment at the Moorfields Eye Hospital (NHS trust). He performed over 300 anterior segment surgery cases during 2 years of fellowship. This enriching and wide eye-opening experience led him to continue clinical and research work in the UK. Under the supervision of Prof. Sue Lightman at Moorfields and Hammersmith hospitals (NHS trusts), he continued subspecialist training in medical retina and uveitis for another 2 years. This period led to the publication of seminal papers including the MUST trial for uveitis and an often-cited clinical trial for the use of methotrexate in inflammatory eye disease. Dr. Pacheco was offered a substantive post as a Specialist Doctor in Ophthalmology at Moorfields, where he continued to practice until 2012. He was a pioneer in the use of anti-VEGF therapy for treating wet AMD, running the very first intravitreal suit clinics at the Moorfields Eye Hospital. He worked tirelessly during those years at the A&E Department, serving the worldwide community that characterizes the ever-changing population of London. Highly trained and highly regarded by his patients and colleagues, Dr. Pacheco continues practicing ophthalmology at a primary-care level, serving local populations at community services as an external provider.
